Search

everythinglearnresearchcommunity

for

Search:↓

The pandemic stress may have increased alopecia cases in Bangladesh.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Nonobese, normotensive Indian women with PCOS may have a higher risk of heart problems linked to inflammation and insulin resistance.

Women with PCOS have worse physical health but similar mental health compared to those without PCOS.

The document is a detailed medical reference on skin and genetic disorders.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

Inclusive and affirming healthcare is essential for improving transgender individuals' quality of life and health.

The document concludes that ongoing medical therapy is crucial for preventing hair loss, and surgical options can restore hair, with future treatments for hair loss being promising.

L-Cystine and L-Cystine with Kera-Diet® safely improved hair and nail quality in healthy women.

Coffee residue extract significantly boosts hair growth.

Eating a balanced diet with vitamins, micronutrients, and antioxidants is important for hair health and can help with hair loss.

Different hair diseases affect people during childbearing years, with treatments ranging from medication to psychological support.

Female relatives of PCOS patients have a higher chance of showing PCOS symptoms.

New techniques and findings in dermatologic surgery show improved pain management, safer liposuction, better hair transplantation, and effective treatments for skin conditions.

Yoga and Ayurveda, including stress management and herbal oil use, can potentially reduce hair loss and promote hair growth, with further research needed for therapy protocols.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Rosacea is a skin condition with unclear causes, classified into four subtypes.

Natural products in cosmetics are beneficial for skin and hair care with low toxicity.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.